Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
2003 2
2004 1
2007 2
2008 1
2010 1
2011 2
2012 2
2014 3
2015 4
2016 5
2017 10
2018 11
2019 18
2020 18
2021 34
2022 15
2023 19
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

137 results

Results by year

Filters applied: . Clear all
Page 1
Biologics and airway remodeling in severe asthma.
Varricchi G, Ferri S, Pepys J, Poto R, Spadaro G, Nappi E, Paoletti G, Virchow JC, Heffler E, Canonica WG. Varricchi G, et al. Among authors: spadaro g. Allergy. 2022 Dec;77(12):3538-3552. doi: 10.1111/all.15473. Epub 2022 Aug 23. Allergy. 2022. PMID: 35950646 Free PMC article. Review.
Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis.
Wechsler ME, Nair P, Terrier B, Walz B, Bourdin A, Jayne DRW, Jackson DJ, Roufosse F, Börjesson Sjö L, Fan Y, Jison M, McCrae C, Necander S, Shavit A, Walton C, Merkel PA; MANDARA Study Group. Wechsler ME, et al. N Engl J Med. 2024 Mar 7;390(10):911-921. doi: 10.1056/NEJMoa2311155. Epub 2024 Feb 23. N Engl J Med. 2024. PMID: 38393328 Clinical Trial.
Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy.
Louis R, Harrison TW, Chanez P, Menzella F, Philteos G, Cosio BG, Lugogo NL, de Luiz G, Burden A, Adlington T, Keeling N, Kwiatek J, Garcia Gil E; ANDHI Study Investigators. Louis R, et al. J Allergy Clin Immunol Pract. 2023 Jun;11(6):1759-1770.e7. doi: 10.1016/j.jaip.2023.03.009. Epub 2023 Mar 21. J Allergy Clin Immunol Pract. 2023. PMID: 36948488 Free article.
Editorial: The Complexity of Primary Antibody Deficiencies.
Quinti I, Spadaro G, Jolles S, Condino-Neto A. Quinti I, et al. Among authors: spadaro g. Front Immunol. 2021 Apr 21;12:635482. doi: 10.3389/fimmu.2021.635482. eCollection 2021. Front Immunol. 2021. PMID: 33968027 Free PMC article. No abstract available.
Exhaled Nitric Oxide as Biomarker of Type 2 Diseases.
Maniscalco M, Fuschillo S, Mormile I, Detoraki A, Sarnelli G, Paulis A, Spadaro G, Cantone E; PATH-2 TASK FORCE. Maniscalco M, et al. Among authors: spadaro g. Cells. 2023 Oct 25;12(21):2518. doi: 10.3390/cells12212518. Cells. 2023. PMID: 37947596 Free PMC article. Review.
Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial.
Harrison TW, Chanez P, Menzella F, Canonica GW, Louis R, Cosio BG, Lugogo NL, Mohan A, Burden A, McDermott L, Garcia Gil E, Zangrilli JG; ANDHI study investigators. Harrison TW, et al. Lancet Respir Med. 2021 Mar;9(3):260-274. doi: 10.1016/S2213-2600(20)30414-8. Epub 2020 Dec 22. Lancet Respir Med. 2021. PMID: 33357499 Clinical Trial.
Epigenetics: An opportunity to shape innate and adaptive immune responses.
Liotti A, Ferrara AL, Loffredo S, Galdiero MR, Varricchi G, Di Rella F, Maniscalco GT, Belardo M, Vastano R, Prencipe R, Pignata L, Romano R, Spadaro G, de Candia P, Pezone A, De Rosa V. Liotti A, et al. Among authors: spadaro g. Immunology. 2022 Dec;167(4):451-470. doi: 10.1111/imm.13571. Epub 2022 Sep 26. Immunology. 2022. PMID: 36043705 Free article. Review.
137 results